BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,452 | 0.0% | 53,824 | 0.0% | 0.01% | 0.0% |
| Q2 2023 | $2,452 | -79.7% | 53,824 | -81.9% | 0.01% | -83.6% |
| Q1 2023 | $12,062 | +99.2% | 297,385 | +164.5% | 0.06% | +90.6% |
| Q4 2022 | $6,056 | -99.9% | 112,435 | 0.0% | 0.03% | 0.0% |
| Q3 2022 | $6,056,000 | -5.8% | 112,435 | +12.3% | 0.03% | 0.0% |
| Q2 2022 | $6,431,000 | -28.2% | 100,126 | -13.3% | 0.03% | -3.0% |
| Q1 2022 | $8,957,000 | -4.8% | 115,515 | +5.4% | 0.03% | +13.8% |
| Q4 2021 | $9,410,000 | +4.7% | 109,628 | -1.9% | 0.03% | -12.1% |
| Q3 2021 | $8,988,000 | -46.5% | 111,755 | -46.4% | 0.03% | +10.0% |
| Q2 2021 | $16,794,000 | -9.2% | 208,630 | -4.9% | 0.03% | -18.9% |
| Q1 2021 | $18,499,000 | -85.6% | 219,338 | -24.7% | 0.04% | -32.7% |
| Q4 2020 | $128,595,000 | +246.0% | 291,388 | -36.9% | 0.06% | -50.0% |
| Q3 2020 | $37,164,000 | -58.1% | 462,134 | -55.2% | 0.11% | -62.7% |
| Q2 2020 | $88,758,000 | +164.4% | 1,030,876 | +149.3% | 0.30% | +5.0% |
| Q1 2020 | $33,567,000 | -54.3% | 413,442 | -52.9% | 0.28% | -39.4% |
| Q4 2019 | $73,379,000 | +43.4% | 877,531 | +50.0% | 0.46% | +23.7% |
| Q3 2019 | $51,165,000 | +42.3% | 584,951 | +33.2% | 0.38% | +34.9% |
| Q2 2019 | $35,955,000 | +58.3% | 439,003 | +57.2% | 0.28% | +48.7% |
| Q1 2019 | $22,710,000 | +142.8% | 279,309 | +96.5% | 0.19% | +79.8% |
| Q4 2018 | $9,354,000 | -24.8% | 142,121 | -11.9% | 0.10% | +10.6% |
| Q3 2018 | $12,439,000 | +53.2% | 161,356 | +46.7% | 0.09% | +32.4% |
| Q2 2018 | $8,119,000 | +55.4% | 109,956 | +36.9% | 0.07% | +47.9% |
| Q1 2018 | $5,224,000 | -1.6% | 80,307 | -2.2% | 0.05% | +6.7% |
| Q4 2017 | $5,310,000 | +8.9% | 82,148 | +5.7% | 0.04% | +2.3% |
| Q3 2017 | $4,877,000 | +10.3% | 77,720 | +6.4% | 0.04% | +2.3% |
| Q2 2017 | $4,422,000 | +18.1% | 73,030 | +1.2% | 0.04% | +26.5% |
| Q1 2017 | $3,744,000 | +34.8% | 72,190 | +15.2% | 0.03% | +21.4% |
| Q4 2016 | $2,778,000 | -7.7% | 62,652 | -0.9% | 0.03% | -22.2% |
| Q3 2016 | $3,009,000 | -78.1% | 63,204 | -79.2% | 0.04% | -81.7% |
| Q2 2016 | $13,745,000 | +65.0% | 303,968 | +49.9% | 0.20% | +42.8% |
| Q1 2016 | $8,330,000 | +374.4% | 202,776 | +340.6% | 0.14% | +331.2% |
| Q4 2015 | $1,756,000 | +15.1% | 46,027 | -0.9% | 0.03% | +3.2% |
| Q3 2015 | $1,526,000 | -16.3% | 46,445 | -3.2% | 0.03% | +34.8% |
| Q2 2015 | $1,823,000 | -57.0% | 47,991 | -22.5% | 0.02% | -57.4% |
| Q1 2015 | $4,244,000 | -73.2% | 61,955 | -71.3% | 0.05% | -71.3% |
| Q4 2014 | $15,825,000 | +12.6% | 215,915 | +10.3% | 0.19% | -61.7% |
| Q3 2014 | $14,054,000 | -21.3% | 195,808 | -20.7% | 0.49% | +140.7% |
| Q2 2014 | $17,853,000 | -6.9% | 246,929 | -5.3% | 0.20% | -32.7% |
| Q1 2014 | $19,182,000 | +10.1% | 260,697 | +4.1% | 0.30% | +14.8% |
| Q4 2013 | $17,425,000 | +8.0% | 250,548 | +2.0% | 0.26% | +1.5% |
| Q3 2013 | $16,137,000 | +12.5% | 245,655 | +18.6% | 0.26% | -2.3% |
| Q2 2013 | $14,347,000 | – | 207,119 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |